Nanocarrier based on the assembly of protein and antisense oligonucleotide to combat multidrug resistance in tumor cells

The Aurora-B-dependent NoCut checkpoint prevents damage of anaphase bridges after DNA replication stress

(2016) Nuno Amaral et al.   NATURE CELL BIOLOGY

Implantable hydrogel embedded dark-gold nanoswitch as a theranostic probe to sense and overcome cancer multidrug resistance

(2015) João Conde et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Cumulative alkylating agent exposure and semen parameters in adult survivors of childhood cancer: a report from the St Jude Lifetime Cohort Study

(2014) Daniel M Green et al.   LANCET ONCOLOGY

The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: A report from the childhood cancer survivor study

(2013) Daniel M. Green et al.   PEDIATRIC BLOOD & CANCER

Effect of MDR modulators verapamil and promethazine on gene expression levels of MDR1 and MRP1 in doxorubicin-resistant MCF-7 cells

(2010) Yaprak Dönmez et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Outcome of Primary Tumor in Patients With Synchronous Stage IV Colorectal Cancer Receiving Combination Chemotherapy Without Surgery As Initial Treatment

(2009) George A. Poultsides et al.   JOURNAL OF CLINICAL ONCOLOGY